Cary, NC, United States of America

Mohammed Kabir

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Emergent Biodefense Operations Lansing LLC. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mohammed Kabir. Retrieved from https://idiyas.com/inventor/mohammed-kabir

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mohammed Kabir: Innovator in Pharmaceutical Formulations

Introduction

Mohammed Kabir is a notable inventor based in Cary, NC (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of medications. His work focuses on improving drug delivery methods to enhance patient outcomes.

Latest Patents

Kabir holds a patent for "Formulations of brincidofovir." This patent discloses formulations that comprise brincidofovir, which can be administered intravenously. These formulations are particularly beneficial for patients who experience gastrointestinal issues when taking the drug orally. Additionally, they are useful in situations where oral administration is not feasible due to underlying health conditions or concerns regarding inadequate oral absorption.

Career Highlights

Kabir is currently employed at Emergent Biodefense Operations Lansing LLC, where he continues to innovate in the field of drug formulations. His expertise in pharmaceutical sciences has positioned him as a valuable asset to his organization.

Collaborations

Some of his coworkers include Irma Marisa Grossi and Odin Johann Naderer. Their collaborative efforts contribute to the advancement of research and development in the pharmaceutical industry.

Conclusion

Mohammed Kabir's work in the formulation of brincidofovir exemplifies his commitment to improving drug delivery systems. His contributions are vital in addressing the challenges faced by patients with specific medical needs.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…